1,261 results match your criteria Archives of Cardiovascular Diseases[Journal]


Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries.

Arch Cardiovasc Dis 2020 May 17. Epub 2020 May 17.

Sorbonne Université, AP-HP, Sorbonne Université, Hôpital Saint Antoine, Service de Pharmacie, 75012 Paris, France; Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France.

Background: Sub-Saharan Africa is experiencing a rising burden of hypertension. Antihypertensive medications and diet are the cornerstone of effective hypertension control.

Aims: To assess adherence to medication and salt restriction in 12 sub-Saharan countries, and to study the relationship between adherence and blood pressure control in patients with hypertension. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.009DOI Listing

Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis.

Arch Cardiovasc Dis 2020 May 1. Epub 2020 May 1.

Department of Pharmacology, CHU de Caen, 14000 Caen, France; Department of Cardiology, CHU de Caen, 14000 Caen, France; Department of Dermatology, CHU de Caen, 14000 Caen, France.

Background: The risk of cardiovascular adverse events from rapidly accelerated fibrosarcoma B-type (BRAF) and mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors is not fully characterized.

Aim: To evaluate the cardiovascular adverse events risks related to BRAF and/or MEK inhibitors in randomized placebo-controlled clinical trials and in the real-life setting.

Methods: We used two approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.014DOI Listing

Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.

Arch Cardiovasc Dis 2020 May 14. Epub 2020 May 14.

Normandie University, UNIROUEN, INSERM U1096, Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France.

Background: Complications decrease after transfemoral transcatheter aortic valve implantation (TAVI), and early discharge is feasible and safe in selected populations.

Aims: To evaluate length of stay (LOS) and reasons for prolonged hospitalisation after transfemoral TAVI in unselected patients.

Methods: Patients with severe aortic stenosis, who had transfemoral TAVI with the SAPIEN 3 prosthesis using exclusively local anaesthesia, were prospectively and consecutively included at five French high-volume centres. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.010DOI Listing

The return of triglycerides and revival of omega-3 fatty acids!

Authors:
Jean Ferrières

Arch Cardiovasc Dis 2020 May 13. Epub 2020 May 13.

Department of Cardiology and Department of Epidemiology, Health Economics and Public Health, UMR INSERM 1027, Toulouse-Rangueil University Hospital, Toulouse University School of Medicine, TSA 50032, 31059 Toulouse cedex 09, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.04.004DOI Listing

Heart failure with preserved ejection fraction: A clustering approach to a heterogenous syndrome.

Arch Cardiovasc Dis 2020 May 11. Epub 2020 May 11.

Department of Cardiology & CIC-IT U 804, Rennes University Hospital, 35000 Rennes, France; Rennes Clinical Investigation Centre, Inserm CIC-0203, CHU de Rennes, 35033 Rennes, France; LTSI, University of Rennes 1, 35042 Rennes, France. Electronic address:

Background: Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome at the crossroads of multiple co-morbidities; there is no valid treatment for this condition. Defining new phenotypes could play a role in improving treatment and prognosis.

Aim: To identify groups with different pathophysiologies by applying a clustering approach to a multicentric cohort of patients with HFpEF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.012DOI Listing

One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.

Arch Cardiovasc Dis 2020 May 28;113(5):303-307. Epub 2020 Apr 28.

Department of Cardiology, Hôpital Universitaire de Montpellier, 34295 Montpellier, France; PhyMedExp, Université de Montpellier, Inserm U1046, CNRS UMR 9214, 34295 Montpellier, France. Electronic address:

Background: Coronavirus disease 2019 (COVID-19) is likely to have significant implications for the cardiovascular care of patients. In most countries, containment has already started (on 17 March 2020 in France), and self-quarantine and social distancing are reducing viral contamination and saving lives. However, these considerations may only be the tip of the iceberg; most resources are dedicated to the struggle against COVID-19, and this unprecedented situation may compromise the management of patients admitted with cardiovascular conditions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186196PMC

Short-term air pollution exposure is a risk factor for acute coronary syndromes in an urban area with low annual pollution rates: Results from a retrospective observational study (2011-2015).

Arch Cardiovasc Dis 2020 May 28;113(5):308-320. Epub 2020 Apr 28.

Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy; IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy.

Background: Epidemiological data suggest that air pollutants are risk factors for cardiovascular disease. Recent studies have questioned the adequacy of current legal pollutant limits, because concentrations lower than those recommended still affect cardiovascular morbidity and mortality.

Aim: To investigate the association between short-term exposure to air pollutants and the daily diagnosis of acute coronary syndrome (ACS) at the emergency department (ED) of S. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.013DOI Listing

Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.

Arch Cardiovasc Dis 2020 May 22;113(5):359-366. Epub 2020 Apr 22.

Service de cardiologie, CHU de Rouen, 76000 Rouen, France.

The introduction of a new technology always raises questions about its place compared with the reference technology. The use of an implantable cardioverter defibrillator to prevent sudden cardiac death is now a widely proven technique, with a clear statement of its indication in the guidelines. More recently, a subcutaneous implantable cardioverter defibrillator has been introduced, and appears to be an attractive technique as it removes the need to implant a lead inside the right ventricle to treat the patient, which should dramatically decrease the risk of complications over time. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.011DOI Listing

How simulation teaching is revolutionizing our relationship with cardiology.

Arch Cardiovasc Dis 2020 May 11;113(5):297-302. Epub 2020 Apr 11.

Inserm UMRS 942, Department of Cardiology, University of Paris, Lariboisière Hospital, Centre Hospitalo-Universitaire Lariboisière, AP-HP, 2, rue Ambroise-Paré, 75010 Paris, France; Division of Cardiology, Johns Hopkins University, 21287-0409 Baltimore, MD, USA; French Commission of Simulation Teaching (Commission d'enseignement par simulation [COMSI]) of the French Society of Cardiology, 75012 Paris, France; Department of Cardiovascular Explorations and Echocardiography, Heart Valve Clinic, CHU de Lille, 59000 Lille, France; Inserm UMR 1011, 59019 Lille, France; Institut Pasteur de Lille, 59000 Lille, France; Department of Cardiology, Cochin Hospital, hôpitaux universitaires Paris Centre, AP-HP, 75014 Paris, France; Inserm U970, Paris Cardiovascular Research Center (PARCC), Georges Pompidou European Hospital, 75015 Paris, France; Department of Cardiology, Foch Hospital, 92150 Suresnes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.010DOI Listing

Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: Mission impossible?

Arch Cardiovasc Dis 2020 Apr 11. Epub 2020 Apr 11.

PhyMedExp, CNRS, Cardiology Department, université de Montpellier, Inserm, CHU de Montpellier, 34295 Montpellier, France.

Cardiogenic shock is a complex clinical entity associated with very high mortality and intensive resource utilization. Despite the widespread use of timely reperfusion and appropriate pharmacotherapy, the survival rate remains at around 50%. Recently, percutaneous axial flow pumps have been integrated into the therapeutic spectrum of cardiogenic shock management. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.02.001DOI Listing

Left-ventricular non-compaction-comparison between different techniques of quantification of trabeculations: Should the diagnostic thresholds be modified?

Arch Cardiovasc Dis 2020 May 2;113(5):321-331. Epub 2020 Apr 2.

Cardiology Department, La Timone Hospital, AP-HM, 13005 Marseille France; Aix Marseille Université, IRD, APHM, MEPHI, IHU - Méditerranée Infection, 13005 Marseille, France. Electronic address:

Background: Diagnosis of left ventricular non-compaction (LVNC) is challenging, and different imaging techniques propose different criteria.

Aim: To compare the value of two-dimensional transthoracic echocardiography (2D-TTE) and cardiac magnetic resonance (CMR) criteria in diagnosing LVNC, and to test a new trabecular quantification method obtained by 2D-TTE, exploring its relationship with CMR non-compacted mass quantification.

Methods: From a multicentre French study, we selected 48 patients with LVNC and 20 with dilated cardiomyopathy (DCM) who underwent 2D-TTE and CMR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.01.004DOI Listing

COVID-19 in patients with cardiovascular diseases.

Arch Cardiovasc Dis 2020 04 31;113(4):225-226. Epub 2020 Mar 31.

Université de Paris, Inserm, PARCC, 75015 Paris, France; CIC1418 and DMU CARTE, hôpital européen Georges-Pompidou, AP-HP, 56, rue Leblanc, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.009DOI Listing

Prognostic value of heart rate reserve is additive to coronary flow velocity reserve during dipyridamole stress echocardiography.

Arch Cardiovasc Dis 2020 Apr 30;113(4):244-251. Epub 2020 Mar 30.

CNR Institute of Clinical Physiology, 56124 Pisa, Italy. Electronic address:

Background: During dipyridamole stress echocardiography (SE), a blunted heart rate reserve (HRR) is a prognostically unfavourable sign of cardiac autonomic dysfunction.

Aim: To assess the prognostic meaning of HRR and coronary flow velocity reserve (CFVR).

Methods: The study group comprised 2149 patients (1236 men; mean age 66±12 years) with suspected (n=1280) or known (n=869) coronary artery disease and without inducible regional wall motion abnormalities (RWMA) during dipyridamole SE (0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.01.005DOI Listing

Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.

Arch Cardiovasc Dis 2020 May 26;113(5):350-358. Epub 2020 Mar 26.

Laboratoire HP2, université Grenoble-Alpes, Grenoble, France; INSERM U1042, Grenoble, France. Electronic address:

Obstructive sleep apnoea syndrome is a growing health concern, affecting nearly one billion people worldwide; it is an independent cardiovascular risk factor, associated with incident obesity, insulin resistance, hypertension, arrhythmias, stroke, coronary artery disease and heart failure. Obstructive sleep apnoea-related cardiovascular and metabolic co-morbidities are a major concern for prognosis and the complexity of obstructive sleep apnoea integrated care. Continuous positive airway pressure, the first-line therapy for the treatment of obstructive sleep apnoea, is highly effective at improving symptoms and quality of life, but has limited effect on co-morbidities. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.01.003DOI Listing

Lipoprotein(a), the rediscovered risk factor, or how to get "back to the future".

Arch Cardiovasc Dis 2020 Mar 20;113(3):147-151. Epub 2020 Mar 20.

Department of Public Health, Imperial College, W6 8RP London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.03.008DOI Listing

Cardiac cell therapy: Current status, challenges and perspectives.

Arch Cardiovasc Dis 2020 Apr 11;113(4):285-292. Epub 2020 Mar 11.

Département de chirurgie cardiovasculaire, hôpital Européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université de Paris, INSERM, PARCC, 75015 Paris, France. Electronic address:

Although the initial clinical trials of cardiac cell therapy have failed to demonstrate unequivocal clinical benefits, the accumulation of preclinical data gathered in parallel can now help us to understand the main causes of failures, while providing mechanistic insights that may be leveraged to improve the outcomes of subsequent clinical studies using cells or their secreted products. This review briefly describes the current status of clinical trials, discusses the potential mechanisms of action of the grafted cells, and the impact of this knowledge on the design of future studies, and finally draws some perspectives. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.01.002DOI Listing

The value of B-type natriuretic peptide plasma concentrations in very old people with chronic peripheral oedema.

Arch Cardiovasc Dis 2020 May 6;113(5):332-340. Epub 2020 Mar 6.

Service de Gériatrie, hôpital Charles-Foix, hôpitaux universitaires Pitié-Salpêtrière-Charles Foix, 7, avenue de la République, 94200 Ivry-sur-Seine, France; Sorbonne Université (UPMC), 75013 Paris, France.

Background: Chronic peripheral oedema is frequent in old patients, and very often results from multiple causes.

Aim: To investigate whether determination of B-type natriuretic peptide plasma concentration helps with the diagnosis of chronic peripheral oedema aetiologies.

Methods: This was a cross-sectional observational study conducted in geriatric hospital wards (intermediate and long-term care) on consecutive in-hospital patients aged>75 years with chronic peripheral oedema and no dyspnoea. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.009DOI Listing

Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.

Arch Cardiovasc Dis 2020 May 27;113(5):341-349. Epub 2020 Feb 27.

Sorbonne Université, ACTION Study Group, INSERM UMRS_1166, Institut de Cardiologie (AP-HP), 75013 Paris, France. Electronic address:

Background: The effect of oral anticoagulation on clinical and haemodynamic outcomes following successful transcatheter aortic valve implantation is unclear.

Aims: To evaluate the effect of oral anticoagulation within the first year after transcatheter aortic valve implantation.

Methods: All patients undergoing transcatheter aortic valve implantation in two French tertiary centres from 2010 to 2016 were included prospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.008DOI Listing

Fetal cardiac interventions: Where do we stand?

Arch Cardiovasc Dis 2020 Feb 26;113(2):121-128. Epub 2020 Feb 26.

Department of Cardiology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.

Fetal cardiac intervention (FCI) is a novel and evolving technique that allows for in utero treatment of a subset of congenital heart disease. This review describes the rationale, selection criteria, technical features, and current outcomes for the three most commonly performed FCI: fetal aortic stenosis with evolving hypoplastic left heart syndrome (HLHS); HLHS with intact or restrictive atrial septum; and pulmonary atresia with intact ventricular septum, with concern for worsening right ventricular (RV) hypoplasia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.06.007DOI Listing
February 2020

Durability of transcatheter aortic valve implantation: A translational review.

Arch Cardiovasc Dis 2020 Mar 26;113(3):209-221. Epub 2020 Feb 26.

Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France; Normandie université, UNIROUEN, INSERM U1096, 76000 Rouen, France. Electronic address:

Until recently, transcatheter aortic valve implantation was restricted to high-risk and inoperable patients. The updated 2017 European Society of Cardiology Guidelines has widened the indication to include intermediate-risk patients, based on two recently published trials (PARTNER 2 and SURTAVI). Moreover, two other recent trials (PARTNER 3 and EVOLUT LOW RISK) have demonstrated similar results with transcatheter aortic valve implantation in low-risk patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.007DOI Listing

New insights into cardiogenic shock and coronary revascularization after acute myocardial infarction.

Arch Cardiovasc Dis 2020 Apr 19;113(4):276-284. Epub 2020 Feb 19.

Cardiology Department, Caremeau University Hospital, ACTION Study Group, Montpellier University, 30029 Nîmes, France.

Cardiogenic shock complicating acute myocardial infarction is challenging, and continues to be associated with high rates of in-hospital and long-term mortality. Coronary revascularization is critical for improving prognosis in CS. Thus, a systematic protocol-driven approach to cardiogenic shock, the development of specialized cardiac care centres, technical advances in interventional cardiology enabling treatment of more complex and severe lesions, the availability of recent antithrombotic therapies and the evolution of new haemodynamic support devices are important considerations in current management of cardiogenic shock complicating acute ischaemic heart disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.005DOI Listing

Right ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation.

Arch Cardiovasc Dis 2020 Feb 18;113(2):113-120. Epub 2020 Feb 18.

Pôle des cardiopathies congénitales de l'enfant et de l'adulte, centre de référence malformations cardiaques congénitales complexes (M3C), hôpital Marie-Lannelongue, université Paris-Sud, université Paris-Saclay, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France.

Background: The indications for percutaneous pulmonary valve implantation (PPVI) have been extended to include large dysfunctional right ventricular outflow tracts (RVOTs). Prestenting of the RVOT is commonly performed before PPVI in order to ensure a stable landing zone. The AndraStent XXL (AndraMed GmbH, Reutlingen, Germany), a cobalt-chromium stent with semi-open cell design, has unique mechanical properties in this indication but is no longer available in France. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.004DOI Listing
February 2020

Infective endocarditis in French Polynesia: Epidemiology, treatments and outcomes.

Arch Cardiovasc Dis 2020 Apr 15;113(4):252-262. Epub 2020 Feb 15.

Department of Cardiology, Rangueil University Hospital, 31059 Toulouse, France; Cardiac Imaging Centre, Toulouse University Hospital, 31400 Toulouse, France; Department of Nuclear Medicine, Rangueil University Hospital, 31059 Toulouse, France; Heart Valve Centre, Toulouse University Hospital, 31400 Toulouse, France. Electronic address:

Background: French Polynesia is a French overseas collectivity in the South Pacific Ocean, where data on infective endocarditis (IE) are lacking.

Aims: To investigate the epidemiology and outcomes of IE in French Polynesia.

Methods: All hospital records from consecutive patients hospitalized in Taaone Hospital, Tahiti, from 2015 to 2018, with an International Classification of Diseases, 10th revision, separation diagnosis of IE (I330), were reviewed retrospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.007DOI Listing

Early exercise training feasibility after aortic valve repair: A multicentre prospective French survey on behalf of the Aortic Valve repair International Registry (AVIATOR).

Arch Cardiovasc Dis 2020 Mar 14;113(3):168-175. Epub 2020 Feb 14.

Montsouris Institut Paris, 75014 Paris, France.

Background: Standardization of aortic valve repair by the external ring annuloplasty approach is an alternative to valve replacement to avoid prosthetic valve-related events. Although the benefit of exercise training to improve postoperative exercise tolerance has been demonstrated in many conditions after cardiac surgery, it has never been described after aortic valve repair.

Objectives: To evaluate the feasibility of an early exercise training programme after aortic valve repair. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.006DOI Listing

Transcatheter congenital interventions performed in low-volume non-surgical centres: Not a problem.

Arch Cardiovasc Dis 2020 Feb 13;113(2):142-145. Epub 2020 Feb 13.

Paediatric and Congenital Cardiology Unit, American Memorial Hospital, CHU Reims, 51092 Reims, France; French Group of Paediatric and Adult Congenital Cardiology, French Society of Cardiology, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.006DOI Listing
February 2020

The difficult balance between thrombosis and bleeding after transcatheter aortic valve replacement: A translational review.

Arch Cardiovasc Dis 2020 Apr 10;113(4):263-275. Epub 2020 Feb 10.

Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Université de Strasbourg, BP 426, 67091 Strasbourg, France; Regenerative NanoMedicine, UMR 1260, Inserm, Université de Strasbourg, 67085 Strasbourg, France.

Transcatheter aortic valve replacement (TAVR) has emerged as the treatment of choice for patients with severe aortic stenosis deemed at high or intermediate risk for cardiac surgery. In light of the latest literature advances, TAVR will undoubtedly concern a growing number of patients because of the progressive extension of its indications. Whereas significant efforts have been made to reduce the burden of periprocedural complications, TAVR still exposes patients to a sizeable number of adverse outcomes, including thrombotic and bleeding events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.003DOI Listing

Transcatheter correction of sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage: The procedure of choice in selected patients?

Arch Cardiovasc Dis 2020 Feb 11;113(2):92-95. Epub 2020 Feb 11.

Department of Congenital Cardiology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, SE1 7EH London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.014DOI Listing
February 2020

Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.

Arch Cardiovasc Dis 2020 Mar 6;113(3):189-198. Epub 2020 Feb 6.

Department of Cardiology, hôpital Robert-Debré, Reims University Hospital, rue du Général-Koenig, 51092 Reims, France.

Background: Transcarotid and trans-subclavian access routes are increasingly used as alternative approaches for transcatheter aortic valve implantation (TAVI) when transfemoral access is not suitable. However, concerns remain about the risk of periprocedural stroke and long-term outcomes following transcarotid/trans-subclavian TAVI.

Aims: The present study sought to compare early and long-term outcomes of transcarotid/trans-subclavian TAVI versus transfemoral TAVI after propensity-score matching. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2020.01.001DOI Listing

Toward a sequential provisional coronary bifurcation stenting technique. From kissing balloon to re-POT sequence.

Arch Cardiovasc Dis 2020 Mar 31;113(3):199-208. Epub 2020 Jan 31.

Department of Interventional Cardiology, Cardiovascular Hospital and Claude-Bernard University, INSERM Unit 1060 CARMEN, Lyon, France.

The specific anatomy of coronary bifurcations makes them prime sites of atherogenesis and complicates revascularization. Account must be taken of the systematic difference in diameter between the 3 constituent vessels so as to minimize final side-branch ostium obstruction and maintain the law of conservation of flow, while respecting the bifurcation angles. Kissing balloon inflation (KBI) was long recommended, but never clearly demonstrated clinical benefit in single-stent provisional stenting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.003DOI Listing

Atrial premature activity detected after an ischaemic stroke unveils atrial myopathy.

Arch Cardiovasc Dis 2020 Apr 29;113(4):227-236. Epub 2020 Jan 29.

Service d'explorations fonctionnelles cardiovasculaires, groupement hospitalier Est, hospices civils de Lyon, hôpital Louis Pradel, 28, avenue Doyen-Lépine, 69677 Bron, France. Electronic address:

Background: Recent publications suggest that left atrial (LA) myopathy is a potential source of thromboembolism, independent of atrial fibrillation.

Aims: We sought to investigate whether the presence of atrial premature activity after an ischaemic stroke is associated with LA remodelling and dysfunction, and might be a surrogate marker of LA myopathy.

Methods: After an ischaemic stroke or a transient ischaemic attack, patients without known atrial fibrillation or overt heart disease were included prospectively in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.002DOI Listing

Incidence, clinical features and outcome of Takotsubo syndrome in the intensive care unit.

Arch Cardiovasc Dis 2020 Mar 23;113(3):176-188. Epub 2020 Jan 23.

Medical Intensive Care Unit, Archet 1 University Hospital, 06200 Nice, France.

Background: Most diseases encountered in the intensive care unit are associated with major stress that can potentially trigger Takotsubo syndrome. Many severe cardiovascular complications are associated with Takotsubo syndrome, yet little is known about Takotsubo syndrome in the intensive care unit.

Aims: We sought to determine the incidence of Takotsubo syndrome, and to describe its clinical features and outcome in an intensive care unit. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.005DOI Listing

Transcatheter interventions in congenital heart disease: We must have the means to fulfil our ambitions.

Arch Cardiovasc Dis 2020 Feb 23;113(2):89-91. Epub 2020 Jan 23.

French Group of Paediatric and Adult Congenital Cardiology, French Society of Cardiology, 75012 Paris, France; French Working Group of Interventional Paediatric and Adult Congenital Cardiology, France; Department of Paediatric and Adult Congenital Cardiology, Bordeaux University Hospital (CHU), 33600 Pessac, France; IHU Liryc, Electrophysiology and Heart Modelling Institute, Fondation Bordeaux Université, 33600 Pessac, France; Centre de Recherche Cardio-Thoracique de Bordeaux, Inserm, U1045, 33000 Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.12.001DOI Listing
February 2020

Hemodynamic comparison between LVAD-bridged heart transplant and standard transplant.

Arch Cardiovasc Dis 2020 Mar 22;113(3):222. Epub 2020 Jan 22.

Division of Cardiology, University of Chicago Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.013DOI Listing

Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Lê VSD Coil: A French multicentre study.

Arch Cardiovasc Dis 2020 Feb 22;113(2):104-112. Epub 2020 Jan 22.

Department of Pediatric and adult congenital heart diseases, M3C Marie-Lannelongue Hospital, Paris-Sud University, 92350 Paris, France.

Background: Transcatheter perimembranous ventricular septal defect (pmVSD) closure remains challenging and is seldom used in France given the risk of atrioventricular block (AVB). pmVSD closure with the Nit-Occlud Lê VSD coil was recently introduced in France as an alternative to occluder devices.

Aims: To study the safety and feasibility of pmVSD closure with the Nit-Occlud Lê VSD coil. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.004DOI Listing
February 2020

Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.

Arch Cardiovasc Dis 2020 Jan 8;113(1):70-84. Epub 2020 Jan 8.

Inserm UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, 92296 Châtenay-Malabry, France. Electronic address:

Pulmonary arterial hypertension is a progressive and lethal cardiopulmonary disease. The rise in right ventricular afterload leads to right ventricular hypertrophy and failure. Right ventricular failure is the most important prognostic factor for morbidity and mortality in pulmonary arterial hypertension or pulmonary hypertension caused by left heart diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.10.009DOI Listing
January 2020

Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases.

Arch Cardiovasc Dis 2020 Jan 6;113(1):5-8. Epub 2020 Jan 6.

Université de Paris, Inserm U970, Paris Cardiovascular Research Center, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.001DOI Listing
January 2020

Will artificial intelligence change the job of the cardiac imaging specialist?

Arch Cardiovasc Dis 2020 Jan 30;113(1):1-4. Epub 2019 Dec 30.

Department of Cardiology, University Hospital, Grenoble Alpes, France; Inserm, U1039, Radiopharmaceutiques Biocliniques, Grenoble Alpes University, France; French Alliance Clinical Trial, French Clinical Research Infrastructure Network, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.11.002DOI Listing
January 2020

Giant coronary aneurysms, from diagnosis to treatment: A literature review.

Arch Cardiovasc Dis 2020 Jan 19;113(1):59-69. Epub 2019 Dec 19.

Department of Cardiology, Hôpital Cochin, AP-HP, 727, rue du Faubourg Saint-Jacques, 75014 Paris, France; Faculté de Médecine, Université Paris Descartes, 75006 Paris, France. Electronic address:

Coronary aneurysms are classically defined as a segment of the artery in which dilation exceeds the diameter of an adjacent portion (considered as a reference point) by more than 1.5times. In rare instances, coronary artery aneurysms are large enough to be called giant coronary artery aneurysms, which have been reported as occurring with an incidence of 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.10.008DOI Listing
January 2020

Analysis of weather exposure 7 days before occurrence of ST-segment elevation myocardial infarction.

Arch Cardiovasc Dis 2020 Jan 18;113(1):22-30. Epub 2019 Dec 18.

Service de cardiologie, hôpital Cavale Blanche, CHRU Brest, 29200 Brest, France. Electronic address:

Background: Several studies have highlighted the relationship between weather patterns and the occurrence of ST-elevation myocardial infarction (STEMI).

Aim: To evaluate the statistical association between the occurrence of STEMI and meteorological variables over the preceding 7 days.

Methods: This was a retrospective study, using prespecified data from the ORBI (Breton Regional Observatory on Myocardial Infarction) registry, which includes all consecutive patients hospitalized for STEMI in the geographical area of Brest, France. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.012DOI Listing
January 2020

Number of electrocardiogram leads in the diagnosis of spontaneous Brugada syndrome.

Arch Cardiovasc Dis 2020 Mar 29;113(3):152-158. Epub 2019 Nov 29.

L'Institut du thorax, Inserm, CNRS, université de Nantes, CHU de Nantes, 44093 Nantes, France. Electronic address:

Background: The recently recommended single lead-based criterion for the diagnosis of Brugada syndrome may lead to overdiagnosis of this disorder and overestimation of the risk of sudden cardiac death.

Aim: To investigate the value of a single-lead diagnosis in patients with Brugada syndrome and a spontaneous type 1 electrocardiogram.

Methods: Consecutive patients with Brugada syndrome were included in a multicentre prospective registry; only those with a spontaneous type 1 electrocardiogram were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.10.007DOI Listing

Hopes and fears of Generation Y congenital cardiac interventionists.

Arch Cardiovasc Dis 2020 Feb 25;113(2):85-88. Epub 2019 Nov 25.

Inserm U1048, I2MC, cardiologie pédiatrique et congénitale, université de Toulouse, hôpital des Enfants, CHU de Toulouse, 31300 Toulouse, France; INSERM U1048 ANS I2MC, Institut des maladies métaboliques et cardiovasculaires, université de Toulouse, BP 84225, 31432 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.011DOI Listing
February 2020

In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort.

Arch Cardiovasc Dis 2019 Nov 21;112(11):657-669. Epub 2019 Nov 21.

Department of Cardiology, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France; INSERM U 970, 75015 Paris, France. Electronic address:

Background: Cancer and acute myocardial infarction (AMI) have important prognostic consequences. Treatment of some cancers may affect coronary artery disease, myocardial function and/or AMI management. Whether the early and long-term mortality of patients with AMI differ according to their history of cancer remains questionable. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.06.012DOI Listing
November 2019
5 Reads

Incidence of, risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation.

Arch Cardiovasc Dis 2019 Dec 20;112(12):765-772. Epub 2019 Nov 20.

ACTION Study Group, Inserm UMRS 1166, institut de cardiologie, Sorbonne université, hôpital universitaire Pitié-Salpêtrière, AP-HP, 75013 Paris, France. Electronic address:

Background: The incidence of and risk factors for readmission for heart failure after successful transcatheter aortic valve implantation (TAVI) are unclear.

Aims: We sought to evaluate the incidence of, risk factors for and clinical impact of readmission for heart failure after successful TAVI in an unselected patient population.

Methods: All patients who underwent successful TAVI in two high-volume French tertiary centres from February 2010 to December 2016 were included prospectively and followed up for 1 year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.008DOI Listing
December 2019

Transcatheter ductus arteriosus stenting in paediatric cardiology: Indications, results and perspectives.

Arch Cardiovasc Dis 2020 Feb 18;113(2):129-141. Epub 2019 Nov 18.

Department of Paediatric and Adult Congenital Cardiology, Bordeaux University Hospital (CHU), avenue Magellan, 33600 Pessac, France; IHU Liryc, Electrophysiology and Heart Modelling Institute, fondation Bordeaux université, 33600 Pessac, France; U1045, Inserm, centre de recherche cardio-thoracique de Bordeaux, 33000 Bordeaux, France; Heart Center, Sidra Medicine, Doha, Qatar.

Stenting the arterial duct emerged in the early 1990s as an alternative to a variety of surgical interventions in neonates with a duct-dependent pulmonary or systemic circulation complex defect. Furthermore, palliative ductal stenting has been applied in older children with severe suprasystemic pulmonary arterial hypertension, as an alternative to surgical shunts, such as Potts anastomosis. Early results of this technique were discouraging, but by learning from the failures of the past, ductal stenting has become a reliable palliative therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.10.004DOI Listing
February 2020

Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.

Arch Cardiovasc Dis 2020 Apr 15;113(4):237-243. Epub 2019 Nov 15.

Department of Intensive Cardiac Care, Hôpital Louis Pradel, Hospices Civils de Lyon, 59, boulevard Pinel, 69677 Bron, France. Electronic address:

Background: Percutaneous assist devices may be used as a bridge to recovery in patients with acute myocardial infarction complicated by cardiogenic shock (CS-AMI).

Aim: To test the hypothesis that the Impella® LP5.0 pump (Abiomed Europe GmbH, Aachen, Germany) provides haemodynamic benefits and improves left ventricular ejection fraction (LVEF) in patients with CS-AMI already managed with an intra-aortic balloon pump (IABP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.10.005DOI Listing

Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome.

Arch Cardiovasc Dis 2020 Jan 14;113(1):40-49. Epub 2019 Nov 14.

Department of Paediatric Cardiology and Paediatric Endocrinology, Centre de Référence pour le Syndrome de Marfan et Apparentés, Hôpital des Enfants, CHU Toulouse, 31300 Toulouse, France.

Background: Little is known about the incidence of cardiovascular events (CVEs) and their associated risk markers in children with Marfan syndrome (MFS).

Aims: To assess the incidence of CVEs and determine risk markers in a cohort diagnosed with Marfan syndrome during childhood and followed for several years.

Methods: From a French multicentre nationwide database, 462 patients with MFS diagnosed during childhood were included prospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.010DOI Listing
January 2020

Coronary angiography in the setting of acute infective endocarditis requiring surgical treatment.

Arch Cardiovasc Dis 2020 Jan 13;113(1):50-58. Epub 2019 Nov 13.

Department of Cardiology, Rangueil University Hospital, 31059 Toulouse, France. Electronic address:

Background: International guidelines recommend that preoperative coronary angiography is performed on patients at risk of coronary disease who have infective endocarditis requiring surgical treatment. However, the risks of contrast-induced nephropathy or vegetation embolization in case of aortic endocarditis should be considered.

Aims: To assess the safety, therapeutic implications and prognostic impact of coronary angiography in patients requiring surgical treatment for active infective endocarditis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2019.09.007DOI Listing
January 2020